Pharma Equity Group A/S: Financial statements 2016
CVR: 26791413
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -2,015,000 compared with DKK -3,742,000 the year before. Equity in the 2016 report amounted to DKK 96,777,000. The solvency ratio was 77%.
- Profit/Loss
- DKK -2,015,000
- Equity
- DKK 96,777,000
- Total Assets
- DKK 125,753,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -2 mio. | 96.8 mio. | - |
| 2015 | - | - | -3.7 mio. | 99.5 mio. | - |
| 2014 | 0 | 0 | -5.9 mio. | 98 mio. | - |
Official annual report
Find more companies like Pharma Equity Group A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of June 29, 2016, Christian Gersdorff Stenbjerre has left the board of directors of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2015. The net result was DKK -3,742,000.
As of February 18, 2016, Niels Troen has joined the board of directors of Pharma Equity Group A/S.
As of February 18, 2016, Leif Reinholdt Erlandsen has left the board of directors of Pharma Equity Group A/S.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.